S&P 500   4,563.04 (-0.69%)
DOW   36,128.29 (-0.32%)
QQQ   384.02 (-1.52%)
AAPL   188.01 (-1.69%)
MSFT   366.47 (-2.15%)
META   316.64 (-2.52%)
GOOGL   128.30 (-2.70%)
AMZN   144.20 (-1.92%)
TSLA   235.92 (-1.22%)
NVDA   452.94 (-3.15%)
NIO   7.26 (+1.54%)
BABA   73.05 (-1.27%)
AMD   117.96 (-2.83%)
T   16.64 (-0.72%)
F   10.77 (+1.80%)
MU   74.07 (-2.45%)
CGC   0.70 (+12.52%)
GE   121.56 (-0.77%)
DIS   91.88 (-0.76%)
AMC   7.02 (+2.33%)
PFE   29.47 (+1.94%)
PYPL   59.73 (+0.13%)
XOM   102.57 (-0.41%)
S&P 500   4,563.04 (-0.69%)
DOW   36,128.29 (-0.32%)
QQQ   384.02 (-1.52%)
AAPL   188.01 (-1.69%)
MSFT   366.47 (-2.15%)
META   316.64 (-2.52%)
GOOGL   128.30 (-2.70%)
AMZN   144.20 (-1.92%)
TSLA   235.92 (-1.22%)
NVDA   452.94 (-3.15%)
NIO   7.26 (+1.54%)
BABA   73.05 (-1.27%)
AMD   117.96 (-2.83%)
T   16.64 (-0.72%)
F   10.77 (+1.80%)
MU   74.07 (-2.45%)
CGC   0.70 (+12.52%)
GE   121.56 (-0.77%)
DIS   91.88 (-0.76%)
AMC   7.02 (+2.33%)
PFE   29.47 (+1.94%)
PYPL   59.73 (+0.13%)
XOM   102.57 (-0.41%)
S&P 500   4,563.04 (-0.69%)
DOW   36,128.29 (-0.32%)
QQQ   384.02 (-1.52%)
AAPL   188.01 (-1.69%)
MSFT   366.47 (-2.15%)
META   316.64 (-2.52%)
GOOGL   128.30 (-2.70%)
AMZN   144.20 (-1.92%)
TSLA   235.92 (-1.22%)
NVDA   452.94 (-3.15%)
NIO   7.26 (+1.54%)
BABA   73.05 (-1.27%)
AMD   117.96 (-2.83%)
T   16.64 (-0.72%)
F   10.77 (+1.80%)
MU   74.07 (-2.45%)
CGC   0.70 (+12.52%)
GE   121.56 (-0.77%)
DIS   91.88 (-0.76%)
AMC   7.02 (+2.33%)
PFE   29.47 (+1.94%)
PYPL   59.73 (+0.13%)
XOM   102.57 (-0.41%)
S&P 500   4,563.04 (-0.69%)
DOW   36,128.29 (-0.32%)
QQQ   384.02 (-1.52%)
AAPL   188.01 (-1.69%)
MSFT   366.47 (-2.15%)
META   316.64 (-2.52%)
GOOGL   128.30 (-2.70%)
AMZN   144.20 (-1.92%)
TSLA   235.92 (-1.22%)
NVDA   452.94 (-3.15%)
NIO   7.26 (+1.54%)
BABA   73.05 (-1.27%)
AMD   117.96 (-2.83%)
T   16.64 (-0.72%)
F   10.77 (+1.80%)
MU   74.07 (-2.45%)
CGC   0.70 (+12.52%)
GE   121.56 (-0.77%)
DIS   91.88 (-0.76%)
AMC   7.02 (+2.33%)
PFE   29.47 (+1.94%)
PYPL   59.73 (+0.13%)
XOM   102.57 (-0.41%)

Haleon Stock Price, News & Analysis (NYSE:HLN)

$8.45
-0.13 (-1.52%)
(As of 11:45 AM ET)
Compare
Today's Range
$8.38
▼
$8.48
50-Day Range
$7.78
▼
$8.63
52-Week Range
$7.07
▼
$9.05
Volume
2.29 million shs
Average Volume
4.41 million shs
Market Capitalization
$39.02 billion
P/E Ratio
N/A
Dividend Yield
1.07%
Price Target
N/A
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Haleon MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.44% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.95mentions of Haleon in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.89%
From $0.45 to $0.49 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.65 out of 5 stars

Medical Sector

876th out of 951 stocks

Toilet Preparations Industry

12th out of 13 stocks

See Top Rated MarketRank™ Stocks Here

HLN stock logo

About Haleon Stock (NYSE:HLN)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.

HLN Stock Price History

HLN Stock News Headlines

December 3, 2023 | americanbankingnews.com
Haleon (NYSE:HLN) Sees Strong Trading Volume
December 1, 2023 | benzinga.com
Looking Into Haleon's Recent Short Interest
December 4, 2023 | Edge On The Street (Ad)
Is This The Most Overlooked Gold Investment Strategy of 2024?
There is little debate on the potential of gold in the next year and decade. The real issue becomes - what's the best gold investment strategy today? Some investors are opting for a unique "royalty" alternative that outshines other options like holding gold bullion or investing in volatile mining stocks.
November 28, 2023 | msn.com
1 Pharma Stock to Buy on Strong Vaccine Growth Potential
November 26, 2023 | americanbankingnews.com
Critical Analysis: Oddity Tech (NASDAQ:ODD) & Haleon (NYSE:HLN)
November 23, 2023 | seekingalpha.com
Haleon's Long-Term Growth Prospects Look Healthy On Solid Macro Trends
November 20, 2023 | seekingalpha.com
Haleon: A Stable Pick
November 7, 2023 | msn.com
The Haleon share price is stuck at £3! Should I invest?
December 4, 2023 | Edge On The Street (Ad)
Is This The Most Overlooked Gold Investment Strategy of 2024?
There is little debate on the potential of gold in the next year and decade. The real issue becomes - what's the best gold investment strategy today? Some investors are opting for a unique "royalty" alternative that outshines other options like holding gold bullion or investing in volatile mining stocks.
November 2, 2023 | lse.co.uk
TOP NEWS: Haleon maintains full-year guidance as profit edges up
November 2, 2023 | nl.investing.com
HALEON ADR winst en omzet lager dan voorspeld
November 2, 2023 | msn.com
Advil maker Haleon's quarterly revenue rises on price hikes, strong demand
October 20, 2023 | msn.com
CVS pulling OTC cold medicines containing nasal decongestant phenylephrine
October 20, 2023 | msn.com
CVS Pulls Some Cold Medicines From Its Shelves. What It Means for Stocks.
August 24, 2023 | finance.yahoo.com
Haleon plc: Recent weakness provides buying opportunity
August 2, 2023 | seekingalpha.com
Haleon plc 2023 Q2 - Results - Earnings Call Presentation
July 26, 2023 | reuters.com
GSK raises 2023 outlook boosted by vaccine, HIV drug sales
July 17, 2023 | finance.yahoo.com
Returns Are Gaining Momentum At Haleon (LON:HLN)
July 14, 2023 | proactiveinvestors.com
Haleon reportedly plans sweeping jobs cuts
July 12, 2023 | msn.com
A Look Into Haleon Inc's Price Over Earnings
June 29, 2023 | seekingalpha.com
Haleon: Leading Business In An Attractive Industry
June 11, 2023 | seekingalpha.com
Haleon: A Hidden Gem In The Consumer Health Market
June 2, 2023 | finance.yahoo.com
Does The Market Have A Low Tolerance For Haleon plc's (LON:HLN) Mixed Fundamentals?
May 24, 2023 | wsj.com
Haleon PLC
May 12, 2023 | msn.com
GSK cuts its Haelon stake in $1B share sale
May 5, 2023 | seekingalpha.com
Haleon: Brand Portfolio Strength Keeps Us Bullish
April 19, 2023 | proactiveinvestors.com
Haleon profit margin may disappoint, says Barclays
See More Headlines
Receive HLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 10/5 Dividend
8/24/2023
Dividend Payable
10/05/2023
Last Earnings
11/02/2023
Today
12/04/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/18/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Toilet preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSE:HLN
CUSIP
N/A
CIK
1900304
Web
www.haleon.com
Phone
44-19-3282-2000
Fax
N/A
Employees
24,622
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
19.07
P/E Growth
2.92
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.53
Current Ratio
0.84
Quick Ratio
0.54

Sales & Book Value

Annual Sales
$13.43 billion
Price / Sales
2.95
Cash Flow
$0.36 per share
Price / Cash Flow
23.78
Book Value
$4.41 per share
Price / Book
1.95

Miscellaneous

Outstanding Shares
4,617,290,000
Free Float
N/A
Market Cap
$39.62 billion
Optionable
Not Optionable
Beta
0.33
Investing Strategies To Help Grow Your Retirement Income Cover
Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Brian McNamara (Age 56)
    CEO & Executive Director
    Comp: $2.93M
  • Mr. Tobias Hestler (Age 50)
    CFO & Executive Director
    Comp: $1.25M
  • Ms. Amy Landucci
    Chief Digital & Technology Officer
  • Ms. Sonya Ghobrial (Age 49)
    Head of Investor Relations
  • Mr. Bjarne Philip Tellmann (Age 56)
    General Counsel
  • Ms. Tamara Rogers (Age 53)
    Chief Marketing Officer
  • Ms. Mairead Nayager (Age 48)
    Chief Human Resources Officer
  • Mr. Bart Derde (Age 53)
    Chief Supply Chain Officer
  • Mr. Filippo Lanzi
    President of EMEA & LatAm
  • Ms. Teri Lyng (Age 60)
    Head of Transformation & Sustainability

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

Should I Buy Haleon Stock? HLN Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Haleon was last updated on Sunday, December 3, 2023 at 5:07 PM.

Pros

Here are some ways that investors could benefit from investing in Haleon plc:

  • Haleon plc is engaged in the research, development, manufacture, and sale of various consumer healthcare products.
  • Haleon plc has a strong track record of innovation and product development.
  • The company has experienced consistent growth in recent periods.
  • Haleon plc has a solid financial position and strong cash flow.
  • The stock price of Haleon plc is currently favorable for investors.

Cons

Investors should be bearish about investing in Haleon plc for these reasons:

  • There may be potential risks associated with the consumer healthcare industry.
  • Competition in the market could impact Haleon plc's market share and profitability.
  • Changes in regulations or government policies could affect the company's operations.
  • Market volatility and economic uncertainties may impact the company's financial performance.
  • Investors should carefully consider their investment goals and risk tolerance before investing in Haleon plc.














HLN Stock Analysis - Frequently Asked Questions

Should I buy or sell Haleon stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" HLN shares.
View HLN analyst ratings or view top-rated stocks.

How have HLN shares performed in 2023?

Haleon's stock was trading at $8.00 on January 1st, 2023. Since then, HLN shares have increased by 5.1% and is now trading at $8.41.
View the best growth stocks for 2023 here.

Are investors shorting Haleon?

Haleon saw a decrease in short interest during the month of October. As of October 31st, there was short interest totaling 21,050,000 shares, a decrease of 7.1% from the October 15th total of 22,660,000 shares. Based on an average daily volume of 5,310,000 shares, the days-to-cover ratio is presently 4.0 days. Approximately 0.5% of the shares of the stock are short sold.
View Haleon's Short Interest.

When is Haleon's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, March 18th 2024.
View our HLN earnings forecast.

How were Haleon's earnings last quarter?

Haleon plc (NYSE:HLN) posted its quarterly earnings data on Thursday, November, 2nd. The company reported $0.10 earnings per share for the quarter. The business had revenue of $3.54 billion for the quarter.

How often does Haleon pay dividends? What is the dividend yield for Haleon?

Haleon announced a -- dividend on Wednesday, August 2nd. Investors of record on Friday, August 25th will be given a dividend of $0.046 per share on Thursday, October 5th. This represents a yield of 1.3%. The ex-dividend date of this dividend is Thursday, August 24th.
Read our dividend analysis for HLN.

Is Haleon a good dividend stock?

Haleon (NYSE:HLN) pays an annual dividend of $0.09 per share and currently has a dividend yield of 1.02%.
Read our dividend analysis for HLN.

What ETFs hold Haleon's stock?

ETFs with the largest weight of Haleon (NYSE:HLN) stock in their portfolio include VanEck Pharmaceutical ETF (PPH), Pacer BioThreat Strategy ETF (VIRS), ClearBridge Focus Value ESG ETF (CFCV), Horizon Kinetics Medical ETF (MEDX),

Who are Haleon's major shareholders?

Haleon's stock is owned by a variety of institutional and retail investors. Top institutional investors include FMR LLC (1.17%), Clearbridge Investments LLC (0.56%), JTC Employer Solutions Trustee Ltd (0.20%), Douglas Lane & Associates LLC (0.17%), Morgan Stanley (0.13%) and Envestnet Asset Management Inc. (0.13%).

How do I buy shares of Haleon?

Shares of HLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:HLN) was last updated on 12/4/2023 by MarketBeat.com Staff

My Account -